2024

1. A Phase Ib Study of the DNA-PK Inhibitor Peposertib Combined with Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer

   Clinical Cancer Research, Vol. 30, Núm. 4, pp. 695-702

2. A Validated Highly Sensitive Microsatellite Instability Assay Accurately Identifies Individuals Harboring Biallelic Germline PMS2 Pathogenic Variants in Constitutional Mismatch Repair Deficiency

   Clinical chemistry, Vol. 70, Núm. 5, pp. 737-746

3. A retrospective study of do-not-do practice recommendations in metastatic breast cancer in Spain

   Revista de Senologia y Patologia Mamaria, Vol. 37, Núm. 3

4. ADAMTS13 recovery in acute thrombotic thrombocytopenic purpura after caplacizumab therapy

   Blood, Vol. 143, Núm. 18, pp. 1807-1815

5. Adaptation and validation of the Physical Restraint-Theory of Planned Behaviour Questionnaire to the paediatric context

   Nursing in Critical Care

6. Age-Related Differences in Takotsubo Syndrome: Results From the Multicenter GEIST Registry

   Journal of the American Heart Association, Vol. 13, Núm. 4, pp. e030623

7. Analysis of the reasons for requesting HIV serology in the emergency department other than those defined in the targeted screening strategy of the “Urgències VIHgila” program and its potential inclusion in a future consensus document

   Enfermedades Infecciosas y Microbiologia Clinica

8. Asociación Española de Neurogastroenterología y Motilidad (ASENEM) updated review on the management of functional abdominal pain

   Gastroenterologia y Hepatologia

9. Bintrafusp Alfa With CCRT Followed by Bintrafusp Alfa Versus Placebo With CCRT Followed by Durvalumab in Patients With Unresectable Stage III NSCLC: A Phase 2 Randomized Study

   Journal of Thoracic Oncology, Vol. 19, Núm. 2, pp. 285-296

10. Blood gene expression biomarkers of response to anti-TNF drugs in pediatric inflammatory bowel diseases before initiation of treatment

    Biomedicine and Pharmacotherapy, Vol. 173

11. Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non-Small-Cell Lung Cancer: Results From the CANOPY-1 Trial

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 42, Núm. 2, pp. 192-204

12. Cell-cycle inhibition and immune microenvironment in breast cancer treated with ribociclib and letrozole or chemotherapy

    npj Breast Cancer, Vol. 10, Núm. 1

13. Chromosomal breaks: another differential gap between early-onset and late-onset colorectal cancers

    British Journal of Surgery, Vol. 111, Núm. 3

14. Chronic Obstructive Lung Disease: Treatment Guidelines and Recommendations for Referral and Multidisciplinary Continuity of Care

    Journal of Clinical Medicine, Vol. 13, Núm. 2

15. Clinical, microbiological, and molecular characterization of pediatric invasive infections by Streptococcus pyogenes in Spain in a context of global outbreak

    mSphere, Vol. 9, Núm. 3

16. Combining loop with thiazide diuretics in patients discharged home after a heart failure decompensation: Association with 30-day outcomes

    European Journal of Internal Medicine

17. Consenso AITP español: Una lista de verificación AITP

    Cirugia pediatrica : organo oficial de la Sociedad Espanola de Cirugia Pediatrica, Vol. 37, Núm. 2, pp. 50-54

18. Consensus statement of the Spanish Society of Neurology on the treatment of multiple sclerosis and holistic patient management in 2023

    Neurologia, Vol. 39, Núm. 2, pp. 196-208

19. Current recommendations for procedure selection in class I and II obesity developed by an expert modified Delphi consensus

    Scientific reports, Vol. 14, Núm. 1, pp. 3445

20. Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022

    eClinicalMedicine, Vol. 71